fraud protection lawyer

Emily C. Lambert


Emily Lambert is an attorney with Kenney & McCafferty. Having joined the firm in 2008,   Ms. Lambert specializes in litigation involving the representation of whistleblowers throughout the United States and abroad in cases involving fraud against the U. S. Government.

Ms. Lambert has worked as counsel on numerous record-setting False Claims Act cases. Most notably Ms. Lambert’s successes have included representing whistleblowers in the largest False Claims Act settlement in history, the July 2012 $3 billion settlement with GlaxoSmithKline, PLC, and the April 2014 $150 million recovery against Amedisys, Inc., the largest recovery against a home health care company under the FCA.

In addition to False Claims Act matters, Ms. Lambert is experienced in successfully representing whistleblowers involving claims brought under the whistleblower reward programs with the Internal Revenue Service and the U.S. Securities and Exchange Commission.

Prior to joining Kenney & McCafferty, Ms. Lambert worked as a criminal prosecutor in the Delaware Attorney General’s Office.

Ms. Lambert’s advocacy on behalf of her clients extends beyond her work with whistleblowers to her service as a volunteer attorney for the Montgomery County Child Advocacy Project (“MCAP”) where she serves as a Guardian Ad Litem for children who are victims of domestic violence. Selected as a “Pennsylvania Super Lawyer Rising Star” from 2010 through 2016 by Philadelphia Magazine, Ms. Lambert received her J.D. from Widener University School of Law and completed her undergraduate studies at Vanderbilt University.


Record setting $3 billion settlement against GlaxoSmithKline in 2012. Kenney & McCafferty represented two whistleblower clients alleging marketing misconduct by GSK with regard to 10 of its drugs, including Advair. To date, the largest settlement in the history of the False Claims Act.

2014 $150 million settlement against Amedisys, Inc. Co-counsel to a group of whistleblowers in what is, to date, the largest home health care settlement in the history of the False Claims Act.

Representation of whistleblower who received $149 million of the $2.2 billion settlement against Johnson & Johnson for alleging a “kickbacks for switches” scheme involving the atypical antipsychotic drug, Risperdal.


J.D., Widener University School of Law
B.A., Interdisciplinary Studies, Vanderbilt University

Start typing and press Enter to search